AzTrials
AzTrials

Maternal MorbidityPATHNCT06941974

Partnering With Antenatal Navigators to Transform Health in Pregnancy

A study testing Patient Navigation Program in people with Maternal Morbidity and Antenatal Health, run by Northwestern University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The Partnering with Antenatal Navigators to Transform Health in Pregnancy (PATH) study aims to evaluate whether an antenatal patient navigation program improves maternal health, neonatal health, pregnant women's experiences, and health care utilization outcomes among low-income pregnant women and their neonates. Read more about this study

Who is it for?
Ages 16 to 50 years, women only
What is being tested?
Patient Navigation Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
600 participants
Where
1 siteUnited States
Study dates
6 Oct 2025to 1 Jun 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 50 years
  • Women only
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Singleton gestation <20 weeks of gestation
  • Nulliparous: no prior pregnancies ≥20 weeks excluding terminations
  • Low income (public insurance or residence in a neighborhood in which >10% of household incomes are <125% of federal poverty line
  • Ability to speak and read English or Spanish
  • Established patient at one of practices associated with Northwestern Medical Group
  • Age 16 years or older

Who cannot join

  • Intent to transfer care to an outside institution
  • Prior enrollment in PATH
  • Concurrent enrollment in a study with competing aims/intervention

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Lynn M Yee, MD, MPH contact

312-472-0119

lynn.yee@northwestern.edu

Brittney R Williams, MPH contact

brittney.williams@northwestern.edu

United States1 site, 1 recruiting
  • Northwestern Memorial Hospital

    Chicago, Illinois, 60611

    Brittney R Williams, MPH, 312-503-3476, brittney.williams@northwestern.edu

    Recruiting

Other trials in United States

About this study

The Partnering with Antenatal Navigators to Transform Health in Pregnancy (PATH) study aims to evaluate whether an antenatal patient navigation program improves maternal health, neonatal health, pregnant women's experiences, and health care utilization outcomes among low-income pregnant women and their neonates. Patient navigation is an individualized, barrier-focused, longitudinal, patient-centered intervention that offers support for a defined set of health services. In this randomized controlled trial, pregnant women who are randomized to receive antenatal patient navigation will be compared to pregnant women who are randomized to receive usual care. Navigators will support pregnant women from before 20 weeks of gestation through 2 weeks postpartum. The PATH intervention will be grounded in understanding and addressing factors that influence health and access to care in order to promote self-efficacy, enhance access, and sustain long-term engagement.

The main objectives of the study are to:

  1. Evaluate whether PATH, compared to usual care, improves maternal health outcomes. We hypothesize the PATH model of antenatal patient navigation for low-income women will reduce the incidence of a composite of adverse maternal outcomes, all of which are known to be increased among women with barriers to care.
  2. Evaluate whether PATH, compared to usual care, improves perinatal health outcomes. We hypothesize PATH will reduce the incidence of a composite of adverse perinatal outcomes. We will also investigate neonatal/pediatric health care utilization.
  3. Evaluate patient, clinician, navigator, and healthcare system experiences with PATH in preparation for widespread implementation and dissemination of the PATH obstetric navigation model. This aim will be accomplished through investigating patient-reported outcomes, completing qualitative and process mapping interviews with navigated participants, and completing qualitative and process mapping interviews with clinicians, navigators, and health administrators.
Read the detailed description

In the US, high rates of maternal morbidity are urgent public health concerns. Limited access to health care combined with other non-medical challenges generate greater risk of adverse maternal and neonatal outcomes for women with low income. High-quality antenatal care supports optimal health, yet typically fails to meet the needs of some populations, including those with lower incomes. Improving the health of pregnant women in a patient-centered manner requires innovative models of care delivery across the spectrum of maternal care. One strategy is patient navigation, a longitudinal, barrier- focused, patient-centered intervention that offers support for health services. Our prior work has included the study of patient navigation for low-income postpartum women, finding that assignment to a navigator improves the receipt of postpartum care and the successful transition to primary care. Although antenatal care is an ideal setting for patient navigation, the benefits of antenatal patient navigation for overall maternal and perinatal health have not been rigorously evaluated in randomized trials. There has been no study of antenatal patient navigation as a comprehensive, wraparound service to improve a wide range of pregnancy outcomes.

This randomized controlled trial aims to test the efficacy of an innovative antenatal care patient navigation model that extends and expands care for low-income pregnant women via the Partnering with Antenatal Navigators to Transform Health in Pregnancy (PATH) Trial. We will randomize nulliparous pregnant women with low income to receive antenatal patient navigation via the PATH program versus usual antenatal care. Participants randomized to receive PATH navigation will receive intensive, individualized patient navigation services throughout pregnancy. As a multilevel, multidomain, intervention, PATH navigation is grounded in understanding and addressing approaches to promote self-efficacy, enhance access, support communication, and sustain healthcare engagement. The PATH navigation program is a comprehensive antenatal patient navigator program which is guided by principles of barrier ascertainment and reduction, promotion of self-efficacy and health literacy skills, facilitation of communication, and enhancing antenatal care access. PATH navigators will incorporate best practices regarding non-medical needs assessment, motivational interviewing, health education, and capacity-building health behavior support.

The study will enroll and randomize 550 to 600 pregnant women, ages 16 and over, who have not had a previous live birth and who have publicly funded prenatal care or have low income. Participants assigned to navigation will be provided intensive, individualized, one-on-one navigation services from enrollment (at less than 20 weeks of gestation) through 2 weeks postpartum. All participants will undergo surveys, interviews, and medical record reviews at 5 study visits from enrollment (<20 weeks of gestation) through 9 months postpartum. Visits will occur at the following intervals: before 20 weeks (V1), 28-32 weeks of gestation (V2), at the time of hospitalization for delivery (V3), 6-12 weeks postpartum (V4), and 9 months postpartum (V5).

Aim 1 will evaluate whether PATH, compared to usual care, improves a composite of maternal adverse outcomes (including hypertensive disorders, preterm birth, postpartum hemorrhage, severe maternal morbidity, maternal mortality). Sub-Aim 1 aims to evaluate whether PATH, compared to usual care, improves effective maternal healthcare utilization (antenatal hospital use, Adequacy of Prenatal Care Utilization index, postpartum care/admission). Aim 2 will evaluate whether PATH, compared to usual care, improves a composite of perinatal adverse outcomes (including neonatal intensive care unit admission, low birthweight, small- and large-for-gestational age, perinatal death). Sub-Aim 2 aims to evaluate whether PATH, compared to usual care, improves effective neonatal/pediatric healthcare utilization (neonatal length-of-stay, neonatal hospital utilization, and pediatric care attendance). Exploratory Aims 1 and 2 will evaluate whether PATH's efficacy varies by different demographic factors (e.g. age), or chronic disease status.

Aim 3 will evaluate patient, clinician, navigator, and health system experiences with PATH in preparation for widespread implementation and dissemination of the PATH obstetric navigation model. This aim is guided by implementation science principles and will be accomplished via serial collection of patient-reported outcomes, individual interviews, and process mapping exercises. Specifically, Aim 3a will compare patient-reported outcomes, including perceived health status, quality of life, patient activation, stress level, and self-efficacy, for women who receive PATH navigation versus usual care. Aim 3b will use qualitative and process mapping methods among approximately 50 participants assigned to PATH to understand participants' engagement, feedback, pregnancy experience, antenatal care processes, and satisfaction with the level of social and medical care received with patient navigation. Aim 3c will similarly use qualitative and process mapping methods with approximately 20 clinicians, navigators, and health system administrators to understand the extent to which PATH facilitated clinical, administrative, and health system needs, as well as lessons for future program implementation, including the relative benefits of discrete elements of the PATH intervention.

The PATH Trial will fill a significant evidence gap by demonstrating whether antenatal patient navigation among low-income pregnant women, who are disproportionately at risk for adverse outcomes, is an effective strategy to improve perinatal health. The expected outcome of this project is to generate the empiric evidence needed to understand the effect of antenatal patient navigation and to plan for an optimized package of successful implementation strategies to prepare for broad dissemination.

Being tested
Patient Navigation Program

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patient Navigation ProgramBehavioural

    PATH navigation is an antenatal patient navigator program designed to reduce barriers to care, enhance access, improve self-efficacy and knowledge, and improve multiple perinatal health outcomes. PATH navigation is a flexible, multi-pronged, patient-centered program with the capacity to evolve with patient needs and preferences. Early in pregnancy, navigators will establish themselves as a non-medical resource and will introduce PATH as a program designed to help inform, support, and connect patients during pregnancy. Navigators will review screen and address supportive and adverse non-medical needs, facilitate communication, perform logistical support, provide advocacy and bridge communication with clinical teams, and perform health education. Navigation services will be tailored to individual medical, psychosocial, or logistical complexity.

Study groups in NCT06941974
Study groupRoleWhat they receive
Navigation GroupExperimentalPregnant participants who are randomized to receive PATH patient navigation will be assigned to a patient navigator. The patient navigator will meet with the patient in early pregnancy for introductions, education, and assessing factors that influence health and access to care. The patient navigator will offer support and resources (e.g., appointment coordination and scheduling, communication with clinical team, transportation, community referrals, support for mental health, support for other non-medical needs, etc.). The navigator will provide support and continue linkage to resources through 2 weeks postpartum.
Receives: Behavioral: Patient Navigation Program
Non-navigation GroupNo interventionNo navigation will be provided; pregnant participants will receive usual care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maternal adverse outcome composite (Aim 1 primary outcome)

    Frequency of maternal composite, which includes hypertensive disorders of pregnancy, preterm birth, postpartum hemorrhage, severe maternal morbidity, or maternal mortality. Components of the primary outcome will also be examined as a score and individually as secondary outcomes (see below).

    Measured: Enrollment through delivery hospitalization, an average of 28 weeks

  2. Neonatal adverse outcome composite (Aim 2 primary outcome)

    Frequency of the neonatal composite, which includes neonatal intensive care unit (NICU) admission, low birthweight, small-for-gestational-age (SGA), large-for-gestational-age (LGA) status, and/or perinatal death. Components of the composite outcome will also be examined as a score and individually as secondary outcomes (see below).

    Measured: At birth/delivery

Secondary outcomes (27)
  1. Hypertensive disorder of pregnancy (component of primary outcome)

    Frequency of de novo hypertensive disorder of pregnancy, including gestational hypertension, preeclampsia with or without severe features, superimposed preeclampsia on chronic hypertension, eclampsia, or HELLP syndrome

    Measured: Enrollment through delivery hospitalization, an average of 28 weeks

  2. Preterm birth (component of primary outcome)

    Frequency of birth less than 37 weeks of gestation

    Measured: Enrollment through delivery hospitalization, an average of 28 weeks

  3. Postpartum hemorrhage (component of primary outcome)

    Frequency of estimated/quantitative blood loss >1000mL (during delivery hospitalization) or blood transfusion

    Measured: At birth/delivery

  4. Severe maternal morbidity (component of primary outcome)

    Frequency of CDC-defined indicators for severe maternal

    Measured: Enrollment through delivery hospitalization, an average of 28 weeks

  5. Maternal mortality (component of primary outcome)

    Frequency of maternal death (any reason) during pregnancy or the delivery hospitalization

    Measured: Enrollment through delivery hospitalization, an average of 28 weeks

  6. Neonatal intensive care unit admission (component of Aim 2 neonatal composite outcome)

    Frequency of admission to the neonatal intensive care unit

    Measured: At birth/delivery

  7. Low birthweight (component of Aim 2 neonatal composite outcome)

    Frequency of birth weight <2500g

    Measured: Immediately post-birth

  8. Small-for-gestational-age (SGA) status (component of Aim 2 neonatal composite outcome)

    Frequency of birth weight <10%ile for gestational age and sex

    Measured: Immediately post-birth

  9. Large-for-gestational-age (LGA) status (component of Aim 2 neonatal composite outcome)

    Frequency of birth weight >90%ile for gestational age and sex

    Measured: Immediately post-birth

  10. Perinatal death (component of Aim 2 neonatal composite outcome)

    Frequency of intrauterine fetal demise (>20 weeks of gestation) or neonatal death (i.e., antenatal, intrapartum, or neonatal death)

    Measured: 20 weeks of gestational through birth hospitalization

  11. Maternal health care utilization: Antenatal hospital utilization

    Frequency of unanticipated obstetric triage or emergency department visit, or antepartum admission

    Measured: Enrollment through delivery

  12. Maternal health care utilization: Antenatal care adequacy

    Adequacy of Prenatal Care Utilization Index score

    Measured: Enrollment through delivery

  13. Maternal health care utilization: Postpartum care

    Frequency of attendance at a routine postpartum care visit within 12 weeks after delivery

    Measured: Between delivery and 12 weeks after delivery

  14. Maternal health care utilization: Postpartum admission or emergency department use

    Frequency of hospital readmission or emergency department use within 9 months of delivery

    Measured: Between delivery and 9 months postpartum

  15. Neonatal health care utilization: Neonatal length of stay

    Neonatal length of birth hospitalization (days)

    Measured: During birth hospitalization

  16. Neonatal health care utilization: Neonatal hospital utilization

    Frequency of neonatal emergency department visit or hospital admission

    Measured: From birth hospital discharge through 9 months

  17. Neonatal health care utilization: Pediatric care attendance

    Frequency of attendance at indicated neonatal/pediatric outpatient care in the recommended time frame in the first 9 months of life

    Measured: From birth hospital discharge through 9 months

  18. Patient-reported outcome: Global health status

    PROMIS Global Health score

    Measured: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum

  19. Patient-reported outcome: Health-related quality of life

    Short Form Health Survey score

    Measured: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum

  20. Patient-reported outcome: Depressive symptoms

    Patient Health Questionnaire-9 score

    Measured: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum

  21. Patient-reported outcome: Anxiety symptoms

    General Anxiety Disorder-7 score

    Measured: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum

  22. Patient-reported outcome: Health-related self-efficacy

    PROMIS Self-Efficacy-General score

    Measured: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum

  23. Patient-reported outcome: Patient activation

    Consumer Health Activation Index score

    Measured: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum

  24. Patient-reported outcome: Difficulties in pregnancy

    nuMoM2b Difficulties in Pregnancy Scale score

    Measured: During pregnancy, delivery hospitalization, and 6-12 weeks postpartum

  25. Patient-reported outcome: Pregnancy experiences

    nuMoM2b Pregnancy Experience Scale-Brief score

    Measured: 3rd trimester, delivery hospitalization

  26. Patient-reported outcome: Stress

    Perceived Stress Scale score

    Measured: During pregnancy, delivery hospitalization, 6-12 weeks postpartum, and 9 months postpartum

  27. Patient-reported outcome: Satisfaction with care (antenatal and postpartum)

    Prenatal Care Satisfaction Scale score and modified scale for postpartum care satisfaction

    Measured: During pregnancy, delivery hospitalization, and 6-12 weeks postpartum

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2025
  2. Study start6 Oct 2025
  3. Primary completion1 Dec 2029 (estimated)
  4. Study completion1 Jun 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
There will be two cohorts: One cohort will be provided intensive, individualized, one-on-one navigation services from early pregnancy (before 20 weeks of gestation) through 2 weeks postpartum. The second cohort will receive usual care. Both cohorts will be followed through 9 months postpartum.
Masking
None (open label)
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06941974
Sponsor's protocol ID
STU00218597
Other IDs
R01MD020130
Acronym
PATH
Status last verified
Apr 2026
First submitted
11 Apr 2025
Last updated
6 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Patient Navigation Program in people with Maternal Morbidity and Antenatal Health, run by Northwestern University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lynn M Yee, MD, MPH (312-472-0119, lynn.yee@northwestern.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maternal adverse outcome composite (Aim 1 primary outcome) (time frame: Enrollment through delivery hospitalization, an average of 28 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in